VIB organizes the 4th edition of Applied Bioinformatics in Life Sciences

On March 10-11, the 4th edition of Applied Bioinformatics in Life Sciences will take place in the Provinciehuis in Leuven, Belgium.

Bioinformatics has quickly become an integral part of life sciences research by enabling innovative computational approaches in an increasingly data-dense environment. Inspired by the sold-out editions in 2016, 2018, and 2020, VIB is organizing this fourth edition to highlight recent developments in bioinformatics research and to showcase its impact on medical, agricultural, and biotechnological research.

Alex Botzki, Head of the VIB Informatics Core, launched this VIB Bioinformatics series in 2016:

‘I am happy to see the Applied Bioinformatics conference series evolve over the past years by following latest developments in computational biology which set the scene for more and more breakthroughs in modern data-intensive life sciences research.’

The conference has attracted many internationally renowned speakers. Anna Kreshuk (Cell Biology and Biophysics, EMBL Heidelberg, DE) will open the session on Image analysis. Smita Krishnaswamy (Yale School of Medicine, US) ​ will focus on deep representation learning methods that are applied to a variety of datasets from cancer biology, immunology, … In the session ‘Proteomics and metabolomics’ Niko Beerenwinkel (ETH, Zurich, CH) will present ‘Computational analysis of tumor single-cell sequencing data’. ‘Integrative analysis of multi-omics data’ is the research topic of Britta Velten (German Cancer Research Center (DKFZ), DE & Wellcome Sanger Institute, UK).

In addition to the plenary presentations, 70 young researchers will present their work during one of the poster sessions. Over 200 people will join the conference live or virtually.

More info

 

Share

Latest stories

Website preview
Scientists discover new gatekeeper cell in the brain
Ghent, 12 February 2026 – VIB and Ghent University researchers have identified and characterized a previously unknown cellular barrier in the brain, which sheds new light on how the brain is protected from the rest of the body. In a study published in Nature Neuroscience, the scientists also reveal a new pathway by which the immune system can impact the brain.
press.vib.be
Website preview
Researchers develop more reliable platform to test antibody medicines
Ghent, 30 January 2026 – An international research consortium has validated a new platform that could change how antibody medicines are tested and brought to patients. The work, published in Science Immunology, highlights problems during conventional antibody drug testing and introduces a next-generation mouse model that makes it possible to predict the effects of antibody drugs in humans more accurately.
press.vib.be
Website preview
Researchers uncover axonal protein synthesis defect in ALS
Leuven, January 12, 2026 – Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS). The study, published in Nature Neuroscience, reveals an early weakness in neurodegeneration and highlights a potential target for future therapies.
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be